Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Entero Therapeutics ( (ENTO) ) just unveiled an announcement.
Entero Therapeutics, Inc. received a letter from Nasdaq on April 11, 2025, indicating non-compliance with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market. The company was granted an extension until October 8, 2025, to regain compliance, which it achieved through a share exchange agreement with GridAI Corp. Nasdaq confirmed compliance on October 28, 2025, but warned that failure to maintain compliance in future reports could lead to delisting.
More about Entero Therapeutics
Average Trading Volume: 1,820,830
Technical Sentiment Signal: Hold
Current Market Cap: $7.04M
Learn more about ENTO stock on TipRanks’ Stock Analysis page.